Compounders Say Shortage Of Weight Loss Drug Continues

By Jared Foretek · April 3, 2025, 8:43 PM EDT

A group of compounding pharmacies looking to keep producing copycat doses of Eli Lilly & Co's lucrative weight loss drug tirzepatide are telling a Texas federal judge that demand for the...

To view the full article, register now.

Try a seven day FREE Trial

Already a subscriber? Click here to login

Documents

Brief

Case Information

Case Title

Outsourcing Facilities Association et al v. United States Food and Drug Administration et al

Case Number

Court

Texas Northern

Nature of Suit

Other Statutes: Administrative Procedure Act/Review or Appeal of Agency Decision

Date Filed

October 07, 2024

Recent Articles By Jared

March 19, 2025
Judge Questions Standing In DEI Executive Orders Challenge
March 18, 2025
States Oppose Term In Sandoz Price-Fixing Deal With Fla.
March 13, 2025
PBMs Tell FTC 5-Month Delay Too Long For In-House Insulin Trial
February 27, 2025
FTC Asks To Delay In-House PBM Insulin Case
February 26, 2025
CVS Ordered To Comply With FTC's PBM Subpoena
January 24, 2025
Biotech Co. Defends Antitrust Counterclaims Against Rival
January 16, 2025
Initial Green Light Given to UnitedHealth's Deal In TCPA Suit
January 14, 2025
FTC Issues Second Report On PBMs, Expanding Study Scope
December 17, 2024
House GOP Asks CVS How Its PBM Treats Smaller Pharmacies
November 14, 2024
Emergency Medical Providers Oppose $2.8B BCBS Deal